Latest news

PCI Biotech: Full year 2017 report – a transformative year

Posted on Mar 20, 2018

Oslo (Norway), 20 March 2018 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its full year result. Please find enclosed the full year 2017 presentation. PCI Biotech Full Year 2017 Presentation 2017 was a year of significant progress for PCI Biotech. The year started with the completion of a strongly supported […]

Annual Report 2017

Posted on Mar 19, 2018

Oslo, Norway, March 19, 2018 The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2017 and the report is attached. The Annual Report 2017 is also available on the company’s website (Annual reports). PCI Biotech Holding ASA Annual Report 2017 For further information, please contact: PCI Biotech Holding ASA, Ullernchausséen […]

Invitation to full year 2017 presentation

Posted on Mar 13, 2018

Oslo, 13 March 2018 – PCI Biotech invites to a presentation of the company’s full year 2017 report on Tuesday 20 March 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday March 20, 08:30am – 09:30am CET (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo […]